Regulation and function of the transferrin receptor 2
转铁蛋白受体2的调节和功能
基本信息
- 批准号:8504642
- 负责人:
- 金额:$ 39.33万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2005
- 资助国家:美国
- 起止时间:2005-07-01 至 2018-03-31
- 项目状态:已结题
- 来源:
- 关键词:AdoptedAnemiaAnemia due to Chronic DisorderArthritisBindingBiological AssayBloodBrainCD81 geneCardiomyopathiesCarrier ProteinsCellsChildChimera organismCirrhosisComplexCytoplasmic TailDependovirusDevelopmentDiabetes MellitusDietDiseaseEquilibriumErythrocytesEuropeanExerciseFailureGenesGeneticGenetic TranscriptionGoalsGrantHeartHepatocyteHereditary hemochromatosisHomeostasisHumanHybridsImpairmentIn TransferrinInborn Genetic DiseasesInterventionIntestinesIronIron OverloadJointsKnock-outLinkLiverLiver CirrhosisMADH6 geneMalignant NeoplasmsMalignant neoplasm of liverModelingMusMutateMutationNeurologicOrganPancreasPathologyPathway interactionsPlayPoint MutationPrimary Cell CulturesProcessProtein EngineeringProteinsRecyclingRefractoryRegulationRelative (related person)ResearchRoleSense OrgansSignal PathwaySignal TransductionSystemTestingThalassemiaTransducersTransferrinTransgenic MiceVenous blood samplingYeastsbasebody sensebone morphogenetic protein 6functional lossgene therapyhepcidinin vivoinnovationinsightknock-downliver injurymacrophagepeptide hormoneprotein protein interactionprotein transportpublic health relevanceresearch studyscaffoldsensortraffickingtransferrin receptor 2uptake
项目摘要
DESCRIPTION (provided by applicant): Hereditary hemochromatosis (HH) is the most common inherited disorder in people of Northern European origin. Iron overload results in damage specific organs leading to cirrhosis of the liver, liver cancer, diabetes, cardiomyopathy, and arthritis. The liver is a major iron-sensing organ in the body. Transferrin is the major iron transport protein in the blood. Mutations in transferrin receptor 2 (TfR2), which is predominantly expressed in hepatocytes and erythrocyte precursors result in HH. Tfr2 forms a complex with HFE, another protein involved in iron homeostasis. Experiments described in this proposal will test the model that the TfR2-HFE complex provides a sensing mechanism to detect iron-loaded Tf and thereby regulates the transcription of hepcidin, a peptide hormone that negatively regulates the efflux of iron out of intestinal cells and macrophages. Alternatively, the TfR2-HFE complex could establish basal levels of hepcidin transcription. Other proteins involved in the complex and in signaling mechanisms will be identified. The long-term goal of this research is to understand how mutations in key proteins disturb the iron balance in the body to reveal the mechanisms by which the body regulates iron-homeostasis.
描述(由申请人提供):遗传性血色病(HH)是北方欧洲血统人群中最常见的遗传性疾病。铁超负荷导致特定器官的损伤,导致肝硬化、肝癌、糖尿病、心肌病和关节炎。肝脏是人体内主要的铁敏感器官。转铁蛋白是血液中主要的铁转运蛋白。转铁蛋白受体2(TfR 2)主要在肝细胞和红细胞前体中表达,其突变导致HH。Tfr 2与HFE形成复合物,HFE是另一种参与铁稳态的蛋白质。本提案中描述的实验将测试TfR 2-HFE复合物提供检测铁负载Tf的传感机制,从而调节铁调素(一种负调节铁从肠细胞和巨噬细胞流出的肽激素)的转录的模型。或者,TfR 2-HFE复合物可以建立铁调素转录的基础水平。将鉴定参与复合物和信号传导机制的其他蛋白质。这项研究的长期目标是了解关键蛋白质的突变如何扰乱体内铁平衡,以揭示身体调节铁稳态的机制。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
CAROLINE ENNS其他文献
CAROLINE ENNS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('CAROLINE ENNS', 18)}}的其他基金
Regulation of hepatic hepcidin expression by transferrin receptor-2
转铁蛋白受体2对肝脏铁调素表达的调节
- 批准号:
10673689 - 财政年份:2021
- 资助金额:
$ 39.33万 - 项目类别:
Regulation of hepatic hepcidin expression by transferrin receptor-2
转铁蛋白受体2对肝脏铁调素表达的调节
- 批准号:
10302636 - 财政年份:2021
- 资助金额:
$ 39.33万 - 项目类别:
Regulation of hepatic hepcidin expression by transferrin receptor-2
转铁蛋白受体2对肝脏铁调素表达的调节
- 批准号:
10471318 - 财政年份:2021
- 资助金额:
$ 39.33万 - 项目类别:
Regulation and function of transferrin receptor 2
转铁蛋白受体2的调节和功能
- 批准号:
7256525 - 财政年份:2005
- 资助金额:
$ 39.33万 - 项目类别:
Regulation and function of the transferrin receptor 2
转铁蛋白受体2的调节和功能
- 批准号:
9016540 - 财政年份:2005
- 资助金额:
$ 39.33万 - 项目类别:
Regulation and function of transferrin receptor 2
转铁蛋白受体2的调节和功能
- 批准号:
7070022 - 财政年份:2005
- 资助金额:
$ 39.33万 - 项目类别:
Regulation and function of transferrin receptor 2
转铁蛋白受体2的调节和功能
- 批准号:
7643459 - 财政年份:2005
- 资助金额:
$ 39.33万 - 项目类别:
Regulation and function of transferrin receptor 2
转铁蛋白受体2的调节和功能
- 批准号:
6962220 - 财政年份:2005
- 资助金额:
$ 39.33万 - 项目类别:
Regulation and function of transferrin receptor 2
转铁蛋白受体2的调节和功能
- 批准号:
7425322 - 财政年份:2005
- 资助金额:
$ 39.33万 - 项目类别:
相似国自然基金
基于构建骨骼类器官模型探究Fanconi anemia信号通路调控电刺激诱导神经化成骨过程的机制研究
- 批准号:82302715
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
FANCM蛋白在传统Fanconi anemia通路以外对保护基因组稳定性的功能
- 批准号:
- 批准年份:2021
- 资助金额:10.0 万元
- 项目类别:省市级项目
范可尼贫血(Fanconi Anemia)基因FANCM在复制后修复中的作用及FA癌症抑制通路的机制研究
- 批准号:31200592
- 批准年份:2012
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Investigation of crosstalk between Fanconi Anemia pathway and ATM for novel therapeutic strategies of chemoresistant ALT-positive high-risk neuroblastoma
范可尼贫血通路与 ATM 之间的串扰研究,用于化疗耐药 ALT 阳性高危神经母细胞瘤的新治疗策略
- 批准号:
24K10442 - 财政年份:2024
- 资助金额:
$ 39.33万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Immune escape mechanisms in BCOR/BCORL1 mutant hematopoietic stem cells from patients with aplastic anemia
再生障碍性贫血患者 BCOR/BCORL1 突变型造血干细胞的免疫逃逸机制
- 批准号:
23K15297 - 财政年份:2023
- 资助金额:
$ 39.33万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Fanconi anemia経路に着目したiPS細胞における高レベル複製ストレスの原因解明
阐明 iPS 细胞中高水平复制应激的原因,重点关注范可尼贫血途径
- 批准号:
23K14452 - 财政年份:2023
- 资助金额:
$ 39.33万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Analysis of the mechanism of hemolytic anemia in canine babesiosis and development of novel therapeutic measures
犬巴贝斯虫病溶血性贫血机制分析及新治疗措施开发
- 批准号:
23KJ0074 - 财政年份:2023
- 资助金额:
$ 39.33万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Brain blood flow, oxygenation, and cognition in adult onset iron deficiency anemia
成人缺铁性贫血的脑血流量、氧合和认知
- 批准号:
10735765 - 财政年份:2023
- 资助金额:
$ 39.33万 - 项目类别:
Chromatin State Alterations in Fanconi Anemia Hematologic Disease and Bone Marrow Failure
范可尼贫血血液疾病和骨髓衰竭中的染色质状态改变
- 批准号:
10735366 - 财政年份:2023
- 资助金额:
$ 39.33万 - 项目类别:
Liver-Gut Axis in Neonatal Anemia and Its Role in RBC Transfusion Associated Gut Injury
新生儿贫血中的肝肠轴及其在红细胞输注相关肠道损伤中的作用
- 批准号:
10583807 - 财政年份:2023
- 资助金额:
$ 39.33万 - 项目类别:
Small Molecule Therapeutics for Sickle Cell Anemia
镰状细胞性贫血的小分子疗法
- 批准号:
10601679 - 财政年份:2023
- 资助金额:
$ 39.33万 - 项目类别:
Accuracy and Feasibility of Non-Invasive Anemia Screening Assistant (ASIST) Device in Resource-Limited Settings
资源有限环境中非侵入性贫血筛查辅助 (ASIST) 设备的准确性和可行性
- 批准号:
10575222 - 财政年份:2023
- 资助金额:
$ 39.33万 - 项目类别:
Mobile phone-based screening for anemia in young children in western Kenya
基于手机的肯尼亚西部幼儿贫血筛查
- 批准号:
10752968 - 财政年份:2023
- 资助金额:
$ 39.33万 - 项目类别: